16 completed, 4 terminated, 2 not yet recruiting, 2 recruiting. 28 Phase 2, 9 Phase 1, 1 Phase 3.
Follow Pancreatitis, Chronic: new trials by email Literature Review of Pancreatitis, Chronic trials Research Report on Pancreatitis, Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pirfenidone as Treatment of Chronic Pancreatitis Pirfenidone 267 mg Oral Tablet, Placebo, PROMIS-Global Health - Chronic Pancreatitis | Phase 2 | Not yet recruiting | Vikas Dudeja | 60 | 2026-08-01 | 2026-08-10 |
| A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors Pancreatectomy, Quality-of-Life Assessment, Treatment Planning - Benign Pancreatic Neoplasm, Chronic Pancreatitis | Phase 1 / Phase 2 | Not yet recruiting | OHSU Knight Cancer Institute | 12 | 2026-07-01 | 2025-11-25 |
| Soy Tomato Juice to Improve Outcomes in Pancreatitis Soy-tomato juice product, Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed - Recurrent Acute Pancreatitis, Chronic Pancreatitis | Phase 1 / Phase 2 | Recruiting | Ohio State University | 35 | 2026-04-02 | 2026-10-20 |
| Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis Standard Varenicline Dosing (1 mg BID), Bupropion 150 mg twice daily, Increased Varenicline Dosing (1mg TID) - Pancreatitis, Chronic, Pancreatitis, Acute | Phase 2 | Withdrawn | Mayo Clinic | 2025-11-06 | 2026-07-07 | |
| Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis/Acute Pancreatitis Associated Diabetes Mellitus Pioglitazone (PIO), Empagliflozin (EMPA) - Pancreatitis, Chronic, Pancreatitis, Acute | Phase 2 | Recruiting | Mayo Clinic | 50 | 2025-05-29 | 2026-07-29 |
| Tocilizumab for Painful Chronic Pancreatitis Tocilizumab 20 MG/ML [Actemra], Sodium Chloride 0.9% Inj - Pancreatitis, Chronic | Phase 2 | Active not recruiting | Soren Schou Olesen | 32 | 2024-05-21 | 2026-08-14 |
| Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis Lidocaine IV - Pancreatic Cancer, Chronic Pancreatitis | Phase 2 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 30 | 2021-01-14 | 2023-10-02 |
| Spinal Cord Stimulation for the Treatment of Pain in Chronic Pancreatitis Spinal Cord Stimulation, Sham - Chronic Pancreatitis, Chronic Pain | Phase 2 | Completed | Aalborg University Hospital | 16 | 2020-11-01 | 2024-01-30 |
| Trial of Indomethacin in Chronic Pancreatitis Indomethacin, Placebo, Endoscopy for Pancreatic Function Testing - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Mayo Clinic | 27 | 2020-07-15 | 2024-09-04 |
| Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT Hydroxychloroquine, Placebo - Chronic Pancreatitis, Insulin Dependent Diabetes | Phase 2 | Completed | The Cleveland Clinic | 9 | 2017-10-03 | 2022-04-08 |
| A Phase IIa Study With Escalating Dose of MS1819-SD MS1819-SD - Chronic Pancreatitis, Distal Pancreatectomy | Phase 2 | Completed | AzurRx SAS | 11 | 2017-01-27 | 2018-09-28 |
| Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis Prolastin-C, Placebo - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 48 | 2017-01-11 | 2023-06-29 |
| Fat Malabsorption in Chronic Pancreatitis Creon36™ - Chronic Pancreatitis | Phase 2 | Completed | Children's Hospital of Philadelphia | 48 | 2016-10-13 | 2019-05-03 |
| Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) EUS-FNB with ProCore needle, EUS-FNB with SharkCore needle, ProCore needle - Mesenchymal Tumor, Autoimmune Pancreatitis | Phase 2 | Withdrawn | Johns Hopkins University | 2016-04-01 | 2017-05-15 | |
| A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 NI-03, Placebo - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Kangen Pharmaceuticals, Inc | 264 | 2016-02-24 | 2022-12-16 |
| Carbon Monoxide-Saturated Medium for Islet Isolation Carbon monoxide-bubbled mediums - Chronic Pancreatitis | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 16 | 2015-01-01 | 2019-01-04 |
| Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain Tetrahydrocannabinol, Placebo - Pancreatitis, Chronic, Abdominal Pain | Phase 2 | Completed | Radboud University Medical Center | 29 | 2012-10-01 | 2014-10-28 |
| Pancreatic Perfusion Using Secretin and MRI Secretin - Chronic Pancreatitis | Phase 1 / Phase 2 | Unknown | University of Nottingham | 15 | 2012-06-01 | 2016-02-18 |
| Rituximab in IgG4-RD: A Phase 1-2 Trial Rituximab - Retroperitoneal Fibrosis, Autoimmune Pancreatitis | Phase 1 / Phase 2 | Completed | Massachusetts General Hospital | 30 | 2012-04-01 | 2017-07-02 |
| Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain Namisol, Diazepam - Cannabinoid, Tetrahydrocannabinol | Phase 2 | Completed | Radboud University Medical Center | 24 | 2011-10-01 | 2013-07-09 |
Showing 20 of 28. Sign in to see all of them.
Pancreatitis (9) · Abdominal Pain (3) · Exocrine Pancreatic Insufficiency (3) · Autoimmune Pancreatitis (2) · Chronic Pain (2) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 1 (2) · Inflammation (2) · Pain (2) · Behavior, Addictive (1) · Bronchiolitis Obliterans Syndrome (1) · Digestive System Diseases (1) · Insulin Resistance (1) · Lymphadenopathy (1)
Chronic Disease (28) · Disease Attributes (28) · Pathologic Processes (28) · Pathological Conditions, Signs and Symptoms (28) · Digestive System Diseases (27) · Pancreatic Diseases (27) · Pancreatitis (19) · Immune System Diseases (5) · Neurologic Manifestations (5) · Signs and Symptoms (5) · Autoimmune Diseases (4) · Endocrine System Diseases (4) · Glucose Metabolism Disorders (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4)
Sodium Chloride (3) · Dronabinol (2) · Pioglitazone (2) · Secretin (2) · BID protein, human (1) · Bupropion (1) · Diazepam (1) · Endoscopy (1) · Hydroxychloroquine (1) · Indomethacin (1) · Pancreatectomy (1) · Pancreatic Polypeptide (1) · Pancrelipase (1) · Pregabalin (1) · Rituximab (1)
Mayo Clinic (3) · Aalborg University Hospital (2) · Johns Hopkins University (2) · Medical University of South Carolina (2) · Radboud University Medical Center (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · AzurRx SAS (1) · ChiRhoClin, Inc. (1) · Children's Hospital of Philadelphia (1) · Kangen Pharmaceuticals, Inc (1) · Massachusetts General Hospital (1) · Meridian Bioscience, Inc. (1) · OHSU Knight Cancer Institute (1) · Ohio State University (1) · Pfizer (1)
United States (15) · Denmark (4) · Netherlands (4) · Russia (2) · Australia (1) · Czechia (1) · France (1) · Hungary (1) · India (1) · Latvia (1) · New Zealand (1) · Poland (1) · Sweden (1) · Ukraine (1) · United Kingdom (1)
Harry van Goor, MD PhD (2) · Hongjun Wang, Ph.D (2) · Arezou Khosroshahi, MD (1) · Babette Zemel, PhD (1) · Betul Hatipoglu, MD (1) · Brett C Sheppard (1) · Dariush Elahi, PhD (1) · Helga A Gulisano, MD (1) · James H Grendell, MD (1) · John H Stone, MD, MPH (1) · John Simpson (1) · Marc G. Besselink, MD PhD MSc (1) · Matthew DiMagno, M.D. (1)
PMID 21848870, PMID 22879908, PMID 23548879, PMID 25667206, PMID 27720917, PMID 31412955, PMID 38103842, PMID 38659255, PMID 40622408
2023 (1), R01DK105183 (1), R01DK138871 (1), R21AA017271 (1), R21DK117212 (1)